By Chantelle Muzanenhamo
The Zimbabwean government has successfully secured an additional three-month supply of antiretroviral (ARV) drugs, ensuring uninterrupted treatment for individuals living with HIV.
Health and Child Care Minister Dr. Douglas Mombeshora confirmed the procurement during a Senate question-and-answer session on Thursday.
The announcement addresses growing concerns over potential shortages of these life-saving medications. Dr. Mombeshora assured lawmakers that the current stock of ARVs would remain sufficient until the end of September, thanks to the recent procurement that complements an earlier six-month supply acquired at the beginning of the year.
This development comes at a time of heightened apprehension regarding possible disruptions to Zimbabwe’s health programs, particularly as U.S. government funding for HIV/AIDS treatment initiatives has seen significant cuts, especially through the President’s Emergency Plan for AIDS Relief (PEPFAR) program.
Dr. Mombeshora explained that the government had utilized domestic resources, including funds from the National AIDS Trust Fund (AIDS Levy), to facilitate the purchase of the new batch of medications.
“We buy a six-month supply. For the first six months up to June, we have enough medicines and tablets. After purchasing the second batch, we will have sufficient supply from June to September,”He stated.
The National AIDS Trust Fund, which is generated from taxes on income, plays a vital role in funding Zimbabwe’s HIV/AIDS response. Established in 1999, the levy has become increasingly important as international funding has dwindled.
Reassuring the public about future supplies, Dr. Mombeshora emphasized the government’s commitment to ensuring the availability of ARVs, stating that there are ongoing discussions with Treasury for additional funding to maintain a continuous supply of HIV treatment options.